to BioTechniques free email alert service to receive content updates.

Biomarker Validation
Featured Protocols
Cancer Biomarkers
. Vendor-submitted protocol . Sponsored by Origene Technologies . Published in November 2007
Latest Protocols
Vendor-submitted protocol. Sponsored by PerkinElmer Published in November 2009
The AlphaLISA® homogenous (i.e., no-wash) immunoassay platform employs a very simple assay protocol that is much faster than a traditional ELISA assay. When compared to competing TR-FRET homogeneous assays, AlphaLISA biomarker assays provide superior performance in terms of sensitivity, dynamic range, and variability.
Cancer Biomarkers
Vendor-submitted protocol. Sponsored by Origene Technologies Published in BioTechniques Protocol Guide 2009
TissueScan is a unique qPCR array for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from thousands of well-documented cancer biopsy samples, normalized, and assembled into ready-to-use gene expression panels.
Cancer Biomarkers
Vendor-submitted protocol. Sponsored by Origene Technologies Published in November 2007
TissueScan is a unique qPCR array of first-strand cDNA from hundreds of clinical tumor samples. It provides a fast and accurate gene expression profiling across a large number of cancer patient samples.
Cancer Biomarkers
Vendor-submitted protocol. Published in December 2006 2007
TissueScan is a unique RT-PCR based system for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from 48 well-documented cancer biopsy samples, normalized and assembled into ready-to-use gene expression panels.
rightcontent.jsp called otherwise condition rightcontent.jsp called 11111111111111111111
Sub-categories
Cancer Biomarkers
Search Protocols
Search our protocols for your specific technique.
[]
Submit Your Protocols
BioTechniques is always looking for author-submitted protocols related to peer-reviewed papers, so submit your protocols today to our editorial team. Suppliers or advertisers interested in publishing their protocols should also submit.
Click here for more information
Categories